VSTM Past Earnings image   This VSTM past earnings page last updated 11/7/2022
VSTM Past Earnings
PeriodPast Earnings DateAdj. EPS
Q3 202211/3/2022-0.080
Q2 20228/8/2022-0.110
Q1 20225/9/2022-0.080
Q4 20213/28/2022-0.080
Q3 202111/4/2021-0.070
Q2 20218/2/2021-0.080
Q1 20215/11/2021-0.070
Q4 20203/18/2021-0.090
Q3 202011/9/20200.110
Q2 20208/10/2020-0.120
Q1 20205/7/2020-0.200
Q4 20193/11/2020-0.400
Q3 201910/29/2019-0.350
Q2 20198/1/2019-0.480
Q1 20195/9/2019-0.520
Q4 20183/12/2019-0.37
Q3 201811/7/2018-0.29
Q2 20188/8/2018-0.3
Q1 20185/3/2018-0.41
Q4 20173/13/2018-0.44
Q3 201711/7/2017-0.61
Q2 20178/8/2017-0.36
Q1 20175/10/2017-0.35
Q4 20163/23/2017-0.32
Q3 201611/7/2016-0.21
Q2 20168/8/2016-0.23
Q1 20165/9/2016-0.22
Q4 20153/3/2016-0.32
Q3 201511/9/2015-0.42
Q2 20158/10/2015-0.42
Q1 20155/11/2015-0.46
Q4 20141/8/2015-0.53
Q3 201410/30/2014-0.52
Q2 20148/7/2014-0.51
Q1 20145/8/2014-0.51
Q4 20133/6/2014-0.450
Q3 201311/12/2013-0.470
Q2 20138/13/2013-0.49
Q1 20135/9/2013-0.440
Q4 20123/27/2013-0.430
Q3 201211/13/2012-0.51
Q2 20128/13/2012-0.34
VSTM Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/3/2022NA
Q2 20228/8/2022NA
Q1 20225/9/20220.00B
Q4 20213/28/20220.00B
Q3 202111/4/20210.00M
Q2 20218/2/20210.00B
Q1 20215/11/20210.00B
Q4 20203/18/20210.00B
Q3 202011/9/20200.08B
Q2 20208/10/20200.00B
Q1 20205/7/20200.01B
Q4 20193/11/20200.00B
Q3 201910/29/20190.01B
Q2 20198/1/20190.00B
Q1 20195/9/20190.00B
Q4 20183/12/20191.21M
Q3 201811/7/201815.51M
Q2 20188/8/201810.00M
Q1 20185/3/2018NA
Q4 20173/13/2018NA
Q3 201711/7/2017NA
Q2 20178/8/2017NA
Q1 20175/10/2017NA
Q4 20163/23/2017NA
Q3 201611/7/2016NA
Q2 20168/8/2016NA
Q1 20165/9/2016NA
Q4 20153/3/2016NA
Q3 201511/9/2015NA
Q2 20158/10/2015NA
Q1 20155/11/2015NA
Q4 20141/8/2015NA
Q3 201410/30/2014NA
Q2 20148/7/2014NA
Q1 20145/8/2014NA
Q4 20133/6/2014NA
Q3 201311/12/2013NA
Q2 20138/13/2013NA
Q1 20135/9/2013NA
Q4 20123/27/2013NA
Q3 201211/13/2012NA
Q2 20128/13/2012NA
Quotes delayed 20 minutes

Email EnvelopeFree VSTM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Verastem Oncology (VSTM) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VTGN Past Earnings
VTRS Past Earnings
VTVT Past Earnings
VVOS Past Earnings
VXRT Past Earnings
VYGR Past Earnings
VYNE Past Earnings
VYNT Past Earnings
WAT Past Earnings
WINT Past Earnings

VSTM Past Earnings Q&A

What was the best and worst VSTM past earnings results?
For Verastem Oncology, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest VSTM past earnings result in our data set was 0.110/share posted in Q3 2020, while the lowest was in Q3 2017 when VSTM posted -0.61/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2020 when VSTM reported 0.08B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at NA of revenue.

  Suggested answer: There are 42 VSTM past earnings results in our data set.

On this page we presented the VSTM past earnings date information for Verastem Oncology. Reviewing that VSTM Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2020, when VSTM posted adjusted EPS of 0.110/share. Meanwhile the lowest VSTM past earnings result was in Q3 2017, when VSTM posted adjusted EPS of -0.61/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2020 when VSTM reported 0.08B in revenue, while the smallest revenue quarter was Q3 2022 when VSTM reported NA in revenue.

Any self directed investor doing their due diligence on VSTM or any other given stock can benefit from researching all of the Verastem Oncology past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Verastem Oncology past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VSTM. Thanks for visiting, and the next time you need to research VSTM past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: HEES Stock Predictions, Everest Re Group 13F Filers, Top Ten Hedge Funds Holding BYBK.

 

VSTM Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.